Company / Book Value per Share
AMICUS THERAPEUTICS, INC. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.917
FY2025
5-year range
$0.441 / $1.173
FY2021-FY2025
Trend
+38.8%
vs FY2024
Sector context
#168 of 209
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s book value per share of $0.917 is lower than 80% of companies in the Health Care sector (FY2025). Book Value per Share has increased for 3 consecutive years, from $0.441 in FY2022 to $0.917 in FY2025.
Based on SEC 10-K filings.
$0.917 in FY2025 with a 5-year CAGR of -3.7%.
Improved from $0.57 to $0.917 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +27.6%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 209This company $0.917 Sector average $189.406
▼
-99.5% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s book value per share has grown for 3 consecutive years.
- 5-year CAGR of -3.7%, indicating a declining trend.
- In FY2025, book value per share increased 38.8% year-over-year.
- Ranks #168 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.917 | +38.8% |
| FY2024 | $0.661 | +16.0% |
| FY2023 | $0.57 | +29.2% |
| FY2022 | $0.441 | -62.4% |
| FY2021 | $1.173 | +6.0% |
| FY2020 | $1.106 | -44.2% |
| FY2019 | $1.982 | +7.4% |
| FY2018 | $1.846 | -25.4% |
| FY2017 | $2.473 | -14.2% |
| FY2016 | $2.881 | -20.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026